» Articles » PMID: 11679237

Clinical Evaluation of the GlucoWatch Biographer: a Continual, Non-invasive Glucose Monitor for Patients with Diabetes

Overview
Date 2001 Oct 27
PMID 11679237
Citations 68
Authors
Affiliations
Soon will be listed here.
Abstract

A device providing frequent, automatic, and non-invasive glucose measurements for persons with diabetes has been developed: the GlucoWatch biographer. This device extracts glucose through intact skin via reverse iontophoresis where it is detected by an amperometric biosensor. The biographer can provide glucose readings every 20 min for 12 h. The performance of this device was evaluated in two large clinical studies in a controlled clinical environment (n=231), and the home environment (n=124). Accuracy of the biographer was evaluated by comparing the automatic biographer readings to serial finger-stick blood glucose (BG) measurements. Biographer performance was comparable in both environments. Mean difference between biographer and finger-stick measurements was -0.01 and 0.26 mmol l(-1) for the clinical and home environments, respectively. The mean absolute value of the relative difference was 1.06 and 1.18 mmol l(-1) for the same studies. Correlation coefficient (r) between biographer and finger-stick measurements was 0.85 and 0.80 for the two studies. In both studies, over 94% of the biographer readings were in the clinically acceptable A+B region of the Clarke Error Grid. A slight positive bias is observed for the biographer readings at low BG levels. Biographer accuracy is relatively constant over all rates of BG changes, except when BG decreases more than 10 mmol l(-1) h(-1), which occurred for only 0.2% of points in the home environment study. Biographer precision, as measured by CV%, is approx. 10%. Skin irritation, characterized by erythema and edema, was either non-existent or mild in >90% of subjects and resolved in virtually all subjects without treatment in several days.

Citing Articles

Improving Electrical Stimulation Effectiveness and Versatility for Non-Invasive Transdermal Monitoring Applications via an Innovative Mixed-Signal Electronic Interface.

Zompanti A, Ciarrocchi D, Grasso S, Olivieri R, Ferri G, Santonico M Sensors (Basel). 2024; 24(23).

PMID: 39686165 PMC: 11645059. DOI: 10.3390/s24237626.


Non-invasive blood glucose monitoring technology in diabetes management: review.

Chandir Moses J, Adibi S, Wickramasinghe N, Nguyen L, Angelova M, Islam S Mhealth. 2024; 10:9.

PMID: 38323150 PMC: 10839510. DOI: 10.21037/mhealth-23-9.


Wearing the Lab: Advances and Challenges in Skin-Interfaced Systems for Continuous Biochemical Sensing.

Watkins Z, McHenry A, Heikenfeld J Adv Biochem Eng Biotechnol. 2024; 187:223-282.

PMID: 38273210 DOI: 10.1007/10_2023_238.


The 3D Printing of Nanocomposites for Wearable Biosensors: Recent Advances, Challenges, and Prospects.

Parupelli S, Desai S Bioengineering (Basel). 2024; 11(1).

PMID: 38247910 PMC: 10813523. DOI: 10.3390/bioengineering11010032.


Conductometric Flexible CuO-Based Sweat-Loss Monitoring Sensor for Future Wearable Technology in Healthcare.

Aydin R, Kahveci O, Akkaya A, Sahin B, Ayyildiz E ACS Omega. 2023; 8(45):42576-42585.

PMID: 38024684 PMC: 10652375. DOI: 10.1021/acsomega.3c05278.